Table 3.
Molecule | Function | Expression in uterine artery ligation |
---|---|---|
Bcl-2 | Anti-apoptotic protein | Reduced (ventricular zone) |
p53 | Pro-apoptotic protein | Increased (cortical zone, CA1 region, subcortical and periventricular white matter, the amygdala) |
Phosphor-p53 | Pro-apoptotic protein | Increased (cortical zone, CA1 region, subcortical and periventricular white matter, the amygdala) |
Murine double minute 2 | Mitigates apoptosis due to p53 | Reduced |
Bcl-2-associated X protein | Pro-apoptotic protein | Increased |
Caspase-3 | DNA fragmentation | Increased |
Inducible NOS | Cerebral pathology associated with apoptosis | Increased (parietal cerebral cortex, ventricular zone) |
Endothelial NOS | Cerebral pathology associated with apoptosis | Increased (ventricular zone) |
BDNF | Support of neuronal survival, differentiation, and growth | Reduced (hippocampus) |
TrkB receptor | Activated by BDNF to support neuronal growth/development | Reduced (hippocampus) |
ErbB3 receptor | Cellular differentiation and proliferation | Reduced (hippocampus) |
NMDA receptor subunits | Cognitive and memory development | Reduced NR1 expression and NR2A–NR2B ratio (hippocampus) |
Bcl-2, B-cell lymphoma 2; BDNF, brain-derived neurotrophic factor; NMDA, N-methyl-D-aspartate; NOS, nitric oxide synthase; TrkB, tyrosine kinase receptor.